Gujarat Ambuja Exports Ltd
Gujarat Ambuja Exports is engaged in the manufacturing of Corn Starch Derivatives, Soya Derivatives, Feed Ingredients, Cotton Yarn, and Edible Oils. Since its incorporation in 1991, GAEL strives to serve the Food, Pharmaceutical, Feed, and many other industries with a long-term growth strategy in the Agro-Processing sector. (Source: Company Website)
- Market Cap ₹ 5,072 Cr.
- Current Price ₹ 111
- High / Low ₹ 145 / 98.7
- Stock P/E 24.6
- Book Value ₹ 67.4
- Dividend Yield 0.23 %
- ROCE 11.5 %
- ROE 8.59 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 3.86% over past five years.
- Company has a low return on equity of 11.9% over last 3 years.
- Dividend payout has been low at 3.17% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,953 | 2,122 | 3,016 | 3,092 | 2,531 | 2,736 | 3,817 | 4,705 | 4,670 | 4,909 | 4,927 | 4,613 | 5,175 | |
| 1,814 | 2,016 | 2,821 | 2,897 | 2,367 | 2,549 | 3,527 | 4,171 | 3,983 | 4,433 | 4,484 | 4,211 | 4,818 | |
| Operating Profit | 140 | 106 | 194 | 195 | 165 | 188 | 289 | 535 | 687 | 476 | 443 | 401 | 357 |
| OPM % | 7% | 5% | 6% | 6% | 6% | 7% | 8% | 11% | 15% | 10% | 9% | 9% | 7% |
| 16 | 5 | 9 | 10 | 9 | 10 | 2 | 27 | 54 | 73 | 144 | 82 | 83 | |
| Interest | 13 | 21 | 22 | 21 | 15 | 10 | 9 | 6 | 6 | 13 | 18 | 17 | 24 |
| Depreciation | 25 | 30 | 37 | 47 | 61 | 65 | 101 | 103 | 97 | 95 | 121 | 126 | 134 |
| Profit before tax | 118 | 61 | 145 | 137 | 98 | 123 | 181 | 452 | 638 | 441 | 448 | 341 | 283 |
| Tax % | 21% | 18% | 22% | 19% | 14% | 16% | 20% | 25% | 26% | 25% | 23% | 27% | |
| 93 | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | 206 | |
| EPS in Rs | 1.68 | 0.90 | 2.04 | 2.01 | 1.52 | 1.87 | 3.18 | 7.37 | 10.36 | 7.20 | 7.54 | 5.44 | 4.51 |
| Dividend Payout % | 9% | 17% | 10% | 9% | 14% | 11% | 8% | 4% | 3% | 5% | 0% | 5% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 4% |
| 3 Years: | 0% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 10% |
| 3 Years: | -19% |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 13% |
| 3 Years: | -3% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 12% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 28 | 23 | 23 | 23 | 23 | 46 | 46 | 46 |
| Reserves | 480 | 528 | 628 | 729 | 800 | 889 | 1,304 | 1,634 | 2,095 | 2,411 | 2,723 | 2,956 | 3,047 |
| 232 | 361 | 183 | 401 | 309 | 329 | 160 | 165 | 281 | 229 | 199 | 231 | 288 | |
| 255 | 223 | 364 | 154 | 148 | 176 | 250 | 341 | 354 | 289 | 342 | 353 | 393 | |
| Total Liabilities | 995 | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,163 | 2,753 | 2,952 | 3,310 | 3,587 | 3,774 |
| 299 | 289 | 458 | 479 | 543 | 562 | 787 | 731 | 771 | 1,042 | 1,037 | 1,179 | 1,175 | |
| CWIP | 45 | 169 | 38 | 64 | 63 | 101 | 12 | 106 | 246 | 87 | 153 | 235 | 335 |
| Investments | 78 | 44 | 44 | 42 | 52 | 73 | 22 | 180 | 714 | 650 | 840 | 938 | 940 |
| 573 | 638 | 662 | 727 | 626 | 686 | 915 | 1,146 | 1,022 | 1,172 | 1,280 | 1,234 | 1,325 | |
| Total Assets | 995 | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,163 | 2,753 | 2,952 | 3,310 | 3,587 | 3,774 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59 | -4 | 294 | -120 | 253 | 135 | 241 | 297 | 596 | 241 | 213 | 341 | |
| -94 | -95 | -79 | -73 | -130 | -130 | -60 | -302 | -777 | -72 | -253 | -336 | |
| 37 | 96 | -209 | 187 | -124 | -3 | -97 | 2 | 100 | -76 | -55 | -13 | |
| Net Cash Flow | 3 | -2 | 6 | -6 | -0 | 2 | 84 | -3 | -81 | 93 | -95 | -8 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 30 | 13 | 18 | 16 | 23 | 15 | 17 | 18 | 21 | 24 | 28 |
| Inventory Days | 88 | 79 | 67 | 75 | 82 | 73 | 74 | 77 | 76 | 69 | 81 | 79 |
| Days Payable | 41 | 29 | 40 | 10 | 12 | 14 | 17 | 18 | 21 | 15 | 18 | 17 |
| Cash Conversion Cycle | 68 | 79 | 41 | 83 | 86 | 82 | 72 | 76 | 73 | 75 | 87 | 90 |
| Working Capital Days | 19 | 10 | 14 | 21 | 30 | 29 | 42 | 44 | 31 | 44 | 56 | 56 |
| ROCE % | 19% | 10% | 19% | 15% | 9% | 11% | 28% | 30% | 18% | 16% | 11% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
27 Nov - CARE reaffirmed CARE AA-; Stable for ₹395 crore bank facilities (enhanced from ₹350 crore) on 26-Nov-2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
21 Nov - Newspaper advertisement for Postal Ballot Notice
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
20 Nov - Postal ballot to approve Dukhabandhu Rath, Yogesh Shah, Gauri Trivedi as independent directors for five years; e-voting Nov 21–Dec 20, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
19 Nov - Sulochana Vijaykumar Gupta resigned as Non-Executive Director effective 19 Nov 2025, citing personal reasons
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10 Nov - Newspaper Publication of Unaudited Financial Results (Standalone and Consolidated) for the second quarter and half year ended 30th September 2025
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
Business Segments